MDMA Is Off the Table, So What's Next for PTSD?The FDA's rejection of MDMA-AT marks another setback in PTSD treatment options, with no new drugs approved in 24 years.
Study Suggests Genetics as a Cause, Not Just a Risk, for Some AlzheimersA new genetic classification could identify up to a fifth of Alzheimer's patients with a known genetic cause, potentially leading to more targeted treatments.
Parkinson's blood test gives early-diagnosis hopeA blood test using AI predicts Parkinson's years before symptoms, providing hope for early diagnosis and treatment.